Publikation

Cost effectiveness of pembrolizumab vs chemotherapy as first-line treatment for metastatic NSCLC that expresses high levels of PD-L1 in Switzerland

Wissenschaftlicher Artikel/Review - 27.12.2019

Bhadhuri Arjun, Insinga Ralph, Guggisberg Patrik, Panje Cédric, Schwenkglenks Matthias